Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation

Identification of targetable molecular changes is essential for selecting appropriate treatment in patients with advanced lung adenocarcinoma. Methods: In this study, a Sanger sequencing plus Fluorescence In Situ Hybridization (FISH) sequential approach was compared with a Next-Generation Sequencing...

ver descrição completa

Detalhes bibliográficos
Autor principal: Fernandes, Maria Gabriela O. (author)
Outros Autores: Jacob, Maria (author), Martins, Natália (author), Moura, Conceição Souto (author), Guimarães, Susana (author), Pereira Reis, Joana (author), Justino, Ana (author), Pina, Maria João (author), Cirnes, Luís (author), Sousa, Catarina (author), Pinto, Josué (author), Marques, José Agostinho (author), Machado, José Carlos (author), Hespanhol, Venceslau (author), Costa, José Luis (author)
Formato: article
Idioma:eng
Publicado em: 2019
Assuntos:
Lung cancer
molecular profiling
next-generation sequencing
argeted therapy
Texto completo:http://hdl.handle.net/10400.22/14843
País:Portugal
Oai:oai:recipp.ipp.pt:10400.22/14843

Texto Completo

http://hdl.handle.net/10400.22/14843

Registos relacionados